Get the Stockscreener App
0.7354
3.24%
-0.0246
After Hours:
.73
-0.0054
-0.73%
Aethlon Medical Inc stock is traded at $0.7354, with a volume of 291.92K.
It is down -3.24% in the last 24 hours and down -18.81% over the past month.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
See More
Previous Close:
$0.76
Open:
$0.7598
24h Volume:
291.92K
Relative Volume:
0.10
Market Cap:
$10.27M
Revenue:
$294.20K
Net Income/Loss:
$-12.25M
P/E Ratio:
-0.1456
EPS:
-5.05
Net Cash Flow:
$-10.77M
1W Performance:
+0.33%
1M Performance:
-18.81%
6M Performance:
+153.59%
1Y Performance:
-58.69%
1-Day Range:
$0.719
$0.7599
1-Week Range:
$0.65
$0.80
52-Week Range:
$0.2375
$1.85
Aethlon Medical Inc Stock (AEMD) Company Profile
Name
Aethlon Medical Inc
Sector
Industry
Phone
619-941-0360
Address
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
0.7354 | 10.27M | 294.20K | -12.25M | -10.77M | -5.05 |
|
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Aethlon Medical Inc Stock (AEMD) Latest News
Aethlon Medical Inc (AEMD) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Aethlon Medical Q3 Earnings Preview: Cancer & Infectious Disease Pipeline Takes Center Stage - StockTitan
Exosome Diagnostics & Therapeutics Market to Grow by USD 1.01 Billion (2025-2029) with Rising Research in Exosome Therapeutics Boosting the Market, Report on How AI is Driving Market TransformationTechnavio - The Malaysian Reserve
Aethlon Medical (AEMD) Projected to Post Earnings on Wednesday - Defense World
Aethlon Medical (NASDAQ:AEMD) Earns Buy Rating from HC Wainwright - Defense World
Aethlon Medical treats first subject with Hemopurifier device in Australia - Medical Device Network
AEMD Treats First Patient in Australian Safety, Feasibility & Dose-Finding Clinical Trial of Hemopurifier - Research Tree
Medical Therapeutic Stock Aethlon Medical, Inc. (NASDAQ: $AEMD) Gains on Cancer Clinical Trial update - Investorideas.com newswire
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Treats First Patient in Australian Hemopurifier® Cancer Trial - Investorideas.com newswire
Aethlon announces treatment of first patient with Hemopurifier in Australia - TipRanks
Revolutionary Blood Filter Could Boost Cancer Immunotherapy Success Rates by 60% - StockTitan
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 201.5% in January - Defense World
Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com - Defense World
StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 201.5% in December - Defense World
Biostage (OTCMKTS:BSTG) and Aethlon Medical (NASDAQ:AEMD) Head to Head Review - Defense World
Aethlon Medical (NASDAQ:AEMD) Coverage Initiated at StockNews.com - Defense World
Head-To-Head Survey: Aethlon Medical (NASDAQ:AEMD) & West Pharmaceutical Services (NYSE:WST) - Defense World
Aethlon Medical receives extension to meet Nasdaq listing requirements - Investing.com
Aethlon Medical receives extension to meet Nasdaq listing requirements By Investing.com - Investing.com UK
Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Co-Diagnostics (NASDAQ:CODX) and Aethlon Medical (NASDAQ:AEMD) Critical Review - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Large Growth in Short Interest - Defense World
Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com - Defense World
Aethlon Medical (NASDAQ:AEMD) Stock Passes Above 200-Day Moving Average – Here’s Why - Defense World
Analyzing SeaStar Medical (NASDAQ:ICU) & Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu - PR Newswire
Aethlon Medical's Hemopurifier Shows 99% Bird Flu Virus Removal in Lab Tests Amid U.S. Outbreak - StockTitan
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Head-To-Head Analysis: AtriCure (NASDAQ:ATRC) and Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 42.1% in November - Defense World
StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Presenting on the Emerging Growth Conference 77 Day 1 on December 4th Register Now - GlobeNewswire
Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 22.7% in November - Defense World
Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
HC Wainwright Reaffirms Buy Rating for Aethlon Medical (NASDAQ:AEMD) - Defense World
Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2025 Earnings Call Transcript - Insider Monkey
Maxim retains hold on Aethlon Medical shares amid clinical progress By Investing.com - Investing.com UK
Aethlon Medical Advances Cancer Trial, Expands Hemopurifier Study Sites Globally | AEMD Stock News - StockTitan
Aethlon Medical Inc (AEMD) Q2 2025 Earnings Call Highlights: Progress in Oncology Trials and ... - Yahoo Finance
Aethlon Medical Reports Progress in Oncology Trials - TipRanks
Aethlon Medical Advances Oncology Trials and Global Expansion - TipRanks
Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update - Kilgore News Herald
Aethlon Medical Launches Groundbreaking Cancer Trial for Hemopurifier Device in Australia | AEMD Stock News - StockTitan
AEMDAETHLON MEDICAL INC Latest Stock News & Market Updates - StockTitan
Aethlon Medical enrols first patient in trial of Hemopurifier device for cancer - Medical Device Network
Aethlon Medical Launches Breakthrough Cancer Trial for Hemopurifier® Treatment | AEMD Stock News - StockTitan
Aethlon Medical Inc Stock (AEMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.14%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):